Back

Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension

29 August 2016 (10:19 - 10:26)
Organised by:
Congress Presentation Part of: Basic mechanisms in pulmonary hypertension Chronic pulmonary hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Byung Ho Lee

Korea Research Institute of Chemical Technology, Daejeon (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
A new experimental model of pulmonary arterial hypertension- KDR knock out
Doctor M. Winter (Vienna, AT)
Abstract Slides
Presentation thumbnail
Hypoxia induces the downregulation of the BMP signalling in pulmonary artery smooth muscle cells through the endothelin system
Doctor H. Maruyama (Tsuchiura, JP)
Abstract Slides
Presentation thumbnail
Hemodynamic and anti-remodelling effect of the rho kinase inhibitor y-27632 in monocrotaline pulmonary arterial hypertension rat model
Doctor S. Cantoni (Parma, IT)
Abstract Slides
Presentation thumbnail
Hypoxia-induced pulmonary hypertension is attenuated by hypoxia-inducible factor-1 alpha deletion in macrophage
Mr H. Kojima (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
Levosimendan prevents and reverts pressure-overload induced right ventricular failure.
Miss M. Hansen (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
Basic mechanisms in pulmonary hypertension

The Event

Event poster

ESC Congress 2016

29 August 2016 10:19 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources